GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 124 filers reported holding GENOMIC HEALTH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | +7.7% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $13,000 | -7.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $14,000 | +40.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $10,000 | +66.7% | 200 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | +20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $7,000 | +75.0% | 200 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
| Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
| EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
| Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
| Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
| Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
| Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
| TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |